1. Home
  2. EVAX vs ETS Comparison

EVAX vs ETS Comparison

Compare EVAX & ETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • ETS
  • Stock Information
  • Founded
  • EVAX 2008
  • ETS 2020
  • Country
  • EVAX Denmark
  • ETS United States
  • Employees
  • EVAX N/A
  • ETS N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ETS Trucking Freight/Courier Services
  • Sector
  • EVAX Health Care
  • ETS Industrials
  • Exchange
  • EVAX Nasdaq
  • ETS Nasdaq
  • Market Cap
  • EVAX 17.8M
  • ETS 15.4M
  • IPO Year
  • EVAX 2021
  • ETS 2025
  • Fundamental
  • Price
  • EVAX $2.94
  • ETS $1.00
  • Analyst Decision
  • EVAX Strong Buy
  • ETS
  • Analyst Count
  • EVAX 2
  • ETS 0
  • Target Price
  • EVAX $10.00
  • ETS N/A
  • AVG Volume (30 Days)
  • EVAX 88.6K
  • ETS 1.9M
  • Earning Date
  • EVAX 10-30-2025
  • ETS 01-01-0001
  • Dividend Yield
  • EVAX N/A
  • ETS N/A
  • EPS Growth
  • EVAX N/A
  • ETS N/A
  • EPS
  • EVAX N/A
  • ETS N/A
  • Revenue
  • EVAX $3,176,000.00
  • ETS $2,542,395.00
  • Revenue This Year
  • EVAX N/A
  • ETS N/A
  • Revenue Next Year
  • EVAX N/A
  • ETS N/A
  • P/E Ratio
  • EVAX N/A
  • ETS N/A
  • Revenue Growth
  • EVAX 1042.45
  • ETS 0.74
  • 52 Week Low
  • EVAX $1.20
  • ETS $0.83
  • 52 Week High
  • EVAX $17.20
  • ETS $4.23
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 52.59
  • ETS N/A
  • Support Level
  • EVAX $2.71
  • ETS N/A
  • Resistance Level
  • EVAX $3.04
  • ETS N/A
  • Average True Range (ATR)
  • EVAX 0.19
  • ETS 0.00
  • MACD
  • EVAX -0.02
  • ETS 0.00
  • Stochastic Oscillator
  • EVAX 57.53
  • ETS 0.00

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: